Crossmark

Engineered sialylated IgG1 Fc as a dose-sparing alternative to IVIG

Crossref DOI link: https://doi.org/10.1038/s41584-025-01347-1

Published Online: 2026-01-05

Published Print: 2026-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Retnakumar, Sruthi Vijaya

Bayry, Jagadeesh https://orcid.org/0000-0003-0498-9808
License Information

Text and Data Mining valid from 2026-01-05

Version of Record valid from 2026-01-05
More Information

Article History

First Online: 5 January 2026

Competing interests

: The authors declare no competing interests.